NOVARTIS PHARMACEUTICALS CORPORATION Federal Contracts — Government Award History
Total (All Time)$47M
Latest FY$34M
Primary AgencyDepartment of Veterans Affairs
NOVARTIS PHARMACEUTICALS CORPORATION has received $47M in total federal contract awards
across 3 fiscal year(s). ▲ 179.3% vs FY2025 Peak year was FY2026 ($34M).
Primary awarding agency: Department of Veterans Affairs.
Data covers largest contracts by award amount. Source: USASpending.gov (FPDS).
Awards by Fiscal Year
| Year | Spending | Total | Contracts | Top Agency |
|---|---|---|---|---|
| FY2026 | $33.5M | 33건 | Department of Veterans Affairs | |
| FY2025 | $12.0M | 19건 | Department of Veterans Affairs | |
| FY2021 | $1.7M | 6건 | Department of Veterans Affairs |
Notable Contracts
| Date | Agency | Amount | Description |
|---|---|---|---|
| 2017-09-14 | Department of Health and Human Services | $30.3M | ELTROMBOPAG: A MEDICAL COUNTERMEASURE TO MITIGATE THROMBOCYTOPENIA FOLLOWING MYE |
| 2026-02-24 | Department of Veterans Affairs | $4.7M | PLUVICTO |
| 2026-02-07 | Department of Veterans Affairs | $4.2M | LU177 – PLUVICTO/LUTATHERA |
| 2025-02-07 | Department of Veterans Affairs | $4.1M | LUTATHERA & PLUVICTO |
| 2025-10-01 | Department of Veterans Affairs | $4.0M | PLUVICTO DRUG |
| 2025-11-01 | Department of Veterans Affairs | $3.9M | PLUVICTO AND LUTATHERA |
| 2024-10-01 | Department of Defense | $3.4M | DELIVERY ORDER FOR PLUVICTO AND LUTATHERA |
| 2025-10-01 | Department of Defense | $3.2M | LUTATHERA AND PLUVICTO |
| 2026-02-01 | Department of Veterans Affairs | $2.4M | RADIOPHARMACEUTICALS PLUVICTO / LUTATHERA |
| 2026-01-01 | Department of Veterans Affairs | $2.0M | RADIOPHARMACEUTICALS-LUTATHERA AND PLUVICTO INJECTIONS |
| 2025-10-01 | Department of Veterans Affairs | $1.2M | PLUVICTO |
| 2026-01-02 | Department of Veterans Affairs | $1.0M | PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML) |
| 2025-10-01 | Department of Veterans Affairs | $996,874 | PLUVICTO FY26 |
| 2025-08-05 | Department of Veterans Affairs | $736,610 | PLUVICTO |
| 2026-02-01 | Department of Veterans Affairs | $685,885 | PLUVICTO |
| 2025-10-01 | Department of Veterans Affairs | $679,949 | LUTATHERA CANCER THERAPY |
| 2026-07-01 | Department of Veterans Affairs | $617,297 | 26AP2812 – PLUVICTO – CLEVELAND VAMC |
| 2026-01-20 | Department of Veterans Affairs | $617,297 | PLUVICTO 2026 – CLEVELAND VAMC |
| 2025-02-05 | Department of Veterans Affairs | $598,125 | PLUVICTO RADIO PHARMA 2025 – CLEVELAND VAMC |
| 2026-01-15 | Department of Defense | $578,754 | ACQUISITION OF PLUVICTO AND LUTATHERA FOR RADIOLOGY PATIENTS. |